Tate & Lyle Stock Rating Reaffirmed by BNP Paribas (TATE)
Tate & Lyle (LON:TATE)‘s stock had its “neutral” rating reiterated by research analysts at BNP Paribas in a report released on Wednesday, American Banking News reports. They currently have a GBX 820 ($13.51) target price on the stock. BNP Paribas’ target price would suggest a potential upside of 4.66% from the company’s current price.
A number of other analysts have also recently weighed in on TATE. Analysts at Credit Suisse reiterated a “neutral” rating on shares of Tate & Lyle in a research note to investors on Thursday, January 9th. They now have a GBX 800 ($13.18) price target on the stock. Separately, analysts at Canaccord Genuity reiterated a “buy” rating on shares of Tate & Lyle in a research note to investors on Tuesday, January 7th. They now have a GBX 900 ($14.83) price target on the stock. Finally, analysts at Galvan Research reiterated a “buy” rating on shares of Tate & Lyle in a research note to investors on Monday, December 23rd. They now have a GBX 840 ($13.84) price target on the stock. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and nine have issued a buy rating to the company. Tate & Lyle currently has a consensus rating of “Hold” and a consensus target price of GBX 859.60 ($14.17).
Shares of Tate & Lyle (LON:TATE) traded down 0.19% during mid-day trading on Wednesday, hitting GBX 783.50. 547,790 shares of the company’s stock traded hands. Tate & Lyle has a 52-week low of GBX 730.50 and a 52-week high of GBX 889.5001. The stock has a 50-day moving average of GBX 788.0 and a 200-day moving average of GBX 799.6. The company’s market cap is £3.638 billion.
Tate & Lyle PLC is a provider of speciality food ingredients and solutions. The Company and its subsidiary and associated undertakings together with its joint ventures develops, manufactures and markets food and industrial ingredients made from renewable resources.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.